Skip to main content
Home > Blog Dr. Partridge to give 2022 Oncology Lecture at American College of Surgeons Congress

Dr. Partridge to give 2022 Oncology Lecture at American College of Surgeons Congress

Edward Partridge

Dr. Partridge invited to present Commission on Cancer Oncology Lecture at 2022 Clinical Congress, American College of Surgeons

We are thrilled to share this news: Guideway Care’s chief medical officer, Dr. Edward Partridge, a former president of the American Cancer Society, will present the Commission on Cancer Oncology Lecture at Clinical Congress 2022, American College of Surgeons on Wednesday, October 19, in San Diego, CA.

Celebrating its 100th year, the Commission on Cancer Care establishes quality standards and accredits cancer programs that are reviewed periodically. Members include surgeons and more than 56 organizations, including government agencies and patient advocacy groups. 

Receiving an invitation from this esteemed consortium of oncology professionals to present the annual oncology lecture is considered a high honor. Dr. Partridge has spent more than forty years helping underserved and under-resourced persons gain better access to cancer screening and treatment. Under his leadership as CMO, Guideway Care helps its partners deliver on the promise of health equity through a unique approach to care guidance, combining human interaction and information technology to ensure patient-centric cancer care that results in the best possible outcomes.

Read more in our latest press release here.

Guiding the Future of Healthcare

A care guidance solution requires collaboration with like-minded partners dedicated to improving health and welfare for entire communities. As your partner, Guideway delivers on the promise of health equity. 

Please contact us if you have questions or need support. For more information on Guideway Care and to view our selection of case studies and white papers, call us.

Contact Us Today To Learn How We Can Help

"*" indicates required fields

This field is for validation purposes and should be left unchanged.

Related Blogs